| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF823 ZHX3 ZBED2 ZNF589 GATA2 WT1 POU3F2 CHD7 FOXA2 ZNF784 EN2 KDM6A ZNF446 HSF5 ZIC3 HOXA1 ZNF646 | 3.54e-06 | 1459 | 66 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF823 ZHX3 ZBED2 ZNF589 GATA2 WT1 GSX2 POU3F2 FOXA2 ZNF784 EN2 ZNF446 ZIC3 HOXA1 ZNF646 | 4.44e-05 | 1412 | 66 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | chromatin binding | 1.47e-04 | 739 | 66 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | GATA2 WT1 POU3F2 CHD7 FOXA2 ZNF784 EN2 KDM6A ZNF446 HSF5 ZIC3 HOXA1 ZNF646 | 1.85e-04 | 1244 | 66 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | GATA2 WT1 POU3F2 CHD7 FOXA2 ZNF784 EN2 KDM6A ZNF446 HSF5 ZIC3 HOXA1 ZNF646 | 2.28e-04 | 1271 | 66 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.47e-04 | 37 | 66 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | zinc ion binding | 6.49e-04 | 891 | 66 | 10 | GO:0008270 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 6.95e-04 | 12 | 66 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.29e-04 | 127 | 66 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 1.42e-03 | 17 | 66 | 2 | GO:0070742 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CCNT2 NCOA6 PRDM9 CAND1 ZNF827 ZBED2 GATA2 WT1 POU3F2 TNKS CHD7 FOXA2 ZNF784 EN2 KDM6A CDON ZIC3 HOXA1 ZNF646 | 4.01e-08 | 1390 | 66 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | semicircular canal development | 5.07e-06 | 11 | 66 | 3 | GO:0060872 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 1.38e-05 | 247 | 66 | 7 | GO:0009952 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | AMOT CECR2 ROR2 GATA2 CHD7 ARID1A FOXA2 KDM6A CDON ZIC3 HOXA1 | 1.48e-05 | 713 | 66 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | brain development | NCOA6 ATXN2 GATA2 GSX2 POU3F2 CHD7 ARID1A FOXA2 EN2 CDON ZIC3 HOXA1 | 1.56e-05 | 859 | 66 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | smoothened signaling pathway | 2.11e-05 | 176 | 66 | 6 | GO:0007224 | |
| GeneOntologyBiologicalProcess | head development | NCOA6 ATXN2 GATA2 GSX2 POU3F2 CHD7 ARID1A FOXA2 EN2 CDON ZIC3 HOXA1 | 3.04e-05 | 919 | 66 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | embryo development | NCOA6 AMOT CECR2 ZBED2 ROR2 GATA2 WT1 CHD7 ARID1A FOXA2 EN2 KDM6A CDON ZIC3 HOXA1 | 3.75e-05 | 1437 | 66 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | segmentation | 4.64e-05 | 123 | 66 | 5 | GO:0035282 | |
| GeneOntologyBiologicalProcess | hindbrain development | 5.37e-05 | 208 | 66 | 6 | GO:0030902 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | MFSD14A PXDN ATXN2 AMOT CECR2 ERVFC1 ROR2 GATA2 WT1 ARID1A FOXA2 KDM6A CDON ZIC3 HOXA1 | 5.39e-05 | 1483 | 66 | 15 | GO:0048646 |
| GeneOntologyBiologicalProcess | anterior/posterior axis specification | 6.68e-05 | 68 | 66 | 4 | GO:0009948 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 7.11e-05 | 561 | 66 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | positive regulation of embryonic development | 8.66e-05 | 27 | 66 | 3 | GO:0040019 | |
| GeneOntologyBiologicalProcess | central nervous system development | NCOA6 ATXN2 ROR2 GATA2 GSX2 POU3F2 CHD7 ARID1A FOXA2 EN2 CDON ZIC3 HOXA1 | 9.11e-05 | 1197 | 66 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.01e-04 | 338 | 66 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.02e-04 | 730 | 66 | 10 | GO:0007423 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.11e-04 | 343 | 66 | 7 | GO:0090596 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.28e-04 | 351 | 66 | 7 | GO:0048562 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA6 AMOT CECR2 ROR2 GATA2 CHD7 ARID1A FOXA2 KDM6A ZIC3 HOXA1 | 1.30e-04 | 906 | 66 | 11 | GO:0043009 |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.35e-04 | 154 | 66 | 5 | GO:0042471 | |
| GeneOntologyBiologicalProcess | regionalization | 1.39e-04 | 478 | 66 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 1.45e-04 | 249 | 66 | 6 | GO:0035264 | |
| GeneOntologyBiologicalProcess | protein localization to chromosome, telomeric region | 1.45e-04 | 32 | 66 | 3 | GO:0070198 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 1.45e-04 | 32 | 66 | 3 | GO:0021533 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 1.59e-04 | 33 | 66 | 3 | GO:1904357 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA6 AMOT CECR2 ROR2 GATA2 CHD7 ARID1A FOXA2 KDM6A ZIC3 HOXA1 | 1.62e-04 | 929 | 66 | 11 | GO:0009792 |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 1.90e-04 | 35 | 66 | 3 | GO:0001702 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 2.07e-04 | 91 | 66 | 4 | GO:0009880 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 2.07e-04 | 91 | 66 | 4 | GO:0048663 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 2.25e-04 | 93 | 66 | 4 | GO:0040014 | |
| GeneOntologyBiologicalProcess | pattern specification process | 2.66e-04 | 526 | 66 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | ear development | 2.99e-04 | 285 | 66 | 6 | GO:0043583 | |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 2.99e-04 | 285 | 66 | 6 | GO:0060828 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 3.29e-04 | 42 | 66 | 3 | GO:0032205 | |
| GeneOntologyBiologicalProcess | neuron fate specification | 3.29e-04 | 42 | 66 | 3 | GO:0048665 | |
| GeneOntologyBiologicalProcess | semicircular canal morphogenesis | 3.58e-04 | 9 | 66 | 2 | GO:0048752 | |
| GeneOntologyBiologicalProcess | outer ear morphogenesis | 4.46e-04 | 10 | 66 | 2 | GO:0042473 | |
| GeneOntologyBiologicalProcess | axis specification | 4.74e-04 | 113 | 66 | 4 | GO:0009798 | |
| GeneOntologyBiologicalProcess | gastrulation | 5.88e-04 | 212 | 66 | 5 | GO:0007369 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical Wnt signaling pathway | 6.13e-04 | 121 | 66 | 4 | GO:0090263 | |
| GeneOntologyBiologicalProcess | embryonic axis specification | 6.18e-04 | 52 | 66 | 3 | GO:0000578 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TLE1 ROR2 GATA2 WT1 GSX2 CHD7 ARID1A FOXA2 KDM6A CDON ZIC3 HOXA1 | 6.23e-04 | 1269 | 66 | 12 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell fate specification | 6.52e-04 | 123 | 66 | 4 | GO:0001708 | |
| GeneOntologyBiologicalProcess | olfactory bulb development | 6.54e-04 | 53 | 66 | 3 | GO:0021772 | |
| GeneOntologyBiologicalProcess | genitalia development | 6.91e-04 | 54 | 66 | 3 | GO:0048806 | |
| GeneOntologyBiologicalProcess | olfactory lobe development | 7.68e-04 | 56 | 66 | 3 | GO:0021988 | |
| GeneOntologyBiologicalProcess | primitive streak formation | 7.69e-04 | 13 | 66 | 2 | GO:0090009 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 7.80e-04 | 129 | 66 | 4 | GO:0042472 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 8.07e-04 | 344 | 66 | 6 | GO:0060070 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | PXDN AMOT CECR2 GATA2 WT1 CHD7 ARID1A FOXA2 KDM6A ZIC3 HOXA1 | 8.20e-04 | 1125 | 66 | 11 | GO:0035239 |
| GeneOntologyBiologicalProcess | somite rostral/caudal axis specification | 8.95e-04 | 14 | 66 | 2 | GO:0032525 | |
| GeneOntologyBiologicalProcess | forebrain development | 9.39e-04 | 489 | 66 | 7 | GO:0030900 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomerase | 9.40e-04 | 60 | 66 | 3 | GO:0032210 | |
| GeneOntologyBiologicalProcess | cochlea development | 9.86e-04 | 61 | 66 | 3 | GO:0090102 | |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell differentiation | 1.03e-03 | 15 | 66 | 2 | GO:0014816 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 1.14e-03 | 368 | 66 | 6 | GO:0030111 | |
| GeneOntologyBiologicalProcess | neuroendocrine cell differentiation | 1.18e-03 | 16 | 66 | 2 | GO:0061101 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 1.21e-03 | 999 | 66 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | inner ear development | 1.30e-03 | 253 | 66 | 5 | GO:0048839 | |
| GeneOntologyBiologicalProcess | regulation of telomere maintenance via telomere lengthening | 1.41e-03 | 69 | 66 | 3 | GO:1904356 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 1.65e-03 | 158 | 66 | 4 | GO:0030177 | |
| GeneOntologyCellularComponent | chromatin | TRIM33 ZHX3 PRDM9 UBR5 ZNF827 CECR2 ZBED2 GSX2 POU3F2 CHD7 ARID1A FOXA2 EN2 ZNF446 HOXA1 | 4.51e-05 | 1480 | 66 | 15 | GO:0000785 |
| HumanPheno | Tetralogy of Fallot | 3.56e-05 | 185 | 27 | 7 | HP:0001636 | |
| HumanPheno | Complex cardiac malformations | 3.62e-05 | 257 | 27 | 8 | HP:0002565 | |
| HumanPheno | Conotruncal defect | 4.39e-05 | 264 | 27 | 8 | HP:0001710 | |
| HumanPheno | Abnormal ventriculoarterial connection | 6.69e-05 | 280 | 27 | 8 | HP:0011563 | |
| HumanPheno | Abnormal connection of the cardiac segments | 7.41e-05 | 284 | 27 | 8 | HP:0011545 | |
| MousePheno | abnormal cerebellum vermis lobule morphology | 2.84e-06 | 8 | 53 | 3 | MP:0009957 | |
| MousePheno | abnormal cerebellar hemisphere morphology | 4.25e-06 | 9 | 53 | 3 | MP:0009959 | |
| MousePheno | perinatal lethality | JPH1 NCOA6 G3BP1 CECR2 ROR2 CPEB4 GATA2 WT1 GSX2 MBD5 ARID1A FOXA2 KDM6A CDON HOXA1 | 1.25e-05 | 1130 | 53 | 15 | MP:0002081 |
| MousePheno | abnormal cerebellum hemisphere lobule morphology | 4.22e-05 | 3 | 53 | 2 | MP:0009963 | |
| MousePheno | abnormal developmental patterning | 5.21e-05 | 577 | 53 | 10 | MP:0002084 | |
| MousePheno | reduced fertility | NCOA6 PRDM9 ATP7B ATXN2 ZBED2 ROR2 WT1 NRG2 CHD7 FOXA2 EN2 ZIC3 | 5.81e-05 | 844 | 53 | 12 | MP:0001921 |
| MousePheno | abnormal vestibular nerve morphology | 8.42e-05 | 4 | 53 | 2 | MP:0004718 | |
| MousePheno | decreased total retina thickness | 9.60e-05 | 197 | 53 | 6 | MP:0011965 | |
| MousePheno | perinatal lethality, incomplete penetrance | 1.02e-04 | 503 | 53 | 9 | MP:0011090 | |
| MousePheno | embryonic growth retardation | TRIM33 NCOA6 CAND1 G3BP1 UBR5 AMOT ROR2 GATA2 CHD7 KDM6A ZIC3 | 1.10e-04 | 763 | 53 | 11 | MP:0003984 |
| MousePheno | abnormal craniofacial morphology | NCOA6 CAND1 G3BP1 UBR5 CECR2 ROR2 MARCHF6 GSX2 CHD7 MBD5 FOXA2 KDM6A CDON ZIC3 HOXA1 | 1.20e-04 | 1372 | 53 | 15 | MP:0000428 |
| MousePheno | craniofacial phenotype | NCOA6 CAND1 G3BP1 UBR5 CECR2 ROR2 MARCHF6 GSX2 CHD7 MBD5 FOXA2 KDM6A CDON ZIC3 HOXA1 | 1.20e-04 | 1372 | 53 | 15 | MP:0005382 |
| MousePheno | abnormal brain development | 1.20e-04 | 638 | 53 | 10 | MP:0000913 | |
| MousePheno | abnormal internal male genitalia morphology | SLC25A3 MFSD14A PRDM9 CAND1 MAN2A2 ATXN2 ROR2 PELI3 CPEB4 MARCHF6 GATA2 WT1 JAZF1 CHD7 HSF5 | 1.41e-04 | 1392 | 53 | 15 | MP:0009205 |
| MousePheno | abnormal male genitalia morphology | SLC25A3 MFSD14A PRDM9 CAND1 MAN2A2 ATXN2 ROR2 PELI3 CPEB4 MARCHF6 GATA2 WT1 JAZF1 CHD7 HSF5 | 1.70e-04 | 1415 | 53 | 15 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | SLC25A3 MFSD14A PRDM9 CAND1 MAN2A2 ATXN2 ROR2 PELI3 CPEB4 MARCHF6 GATA2 WT1 JAZF1 CHD7 HSF5 | 1.70e-04 | 1415 | 53 | 15 | MP:0001145 |
| MousePheno | abnormal cardiovascular development | NCOA6 UBR5 AMOT GATA2 WT1 CHD7 ARID1A FOXA2 KDM6A ZIC3 HOXA1 | 1.72e-04 | 802 | 53 | 11 | MP:0002925 |
| MousePheno | abnormal macrophage cytokine production | 1.75e-04 | 29 | 53 | 3 | MP:0011072 | |
| MousePheno | abnormal nervous system development | NCOA6 UBR5 CECR2 CPEB4 GSX2 TNKS CHD7 ARID1A FOXA2 EN2 KDM6A CDON ZIC3 HOXA1 | 1.77e-04 | 1257 | 53 | 14 | MP:0003861 |
| MousePheno | abnormal craniofacial development | 1.82e-04 | 425 | 53 | 8 | MP:0003935 | |
| MousePheno | abnormal total retina thickness | 1.89e-04 | 223 | 53 | 6 | MP:0011963 | |
| MousePheno | facial asymmetry | 2.10e-04 | 6 | 53 | 2 | MP:0030099 | |
| MousePheno | delayed neural tube closure | 2.15e-04 | 31 | 53 | 3 | MP:0002621 | |
| MousePheno | abnormal circumventricular organ morphology | 2.15e-04 | 31 | 53 | 3 | MP:0013562 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | NCOA6 ATP7B CECR2 CPEB4 GATA2 TAB2 CHD7 MBD5 FOXA2 KDM6A CDON ZIC3 HOXA1 | 2.21e-04 | 1124 | 53 | 13 | MP:0011112 |
| MousePheno | abnormal embryonic growth/weight/body size | TRIM33 NCOA6 CAND1 G3BP1 UBR5 AMOT ROR2 GATA2 WT1 CHD7 ARID1A FOXA2 KDM6A ZIC3 | 2.43e-04 | 1295 | 53 | 14 | MP:0002088 |
| MousePheno | abnormal embryonic-extraembryonic boundary morphology | 2.83e-04 | 34 | 53 | 3 | MP:0003890 | |
| MousePheno | abnormal malleus morphology | 2.83e-04 | 34 | 53 | 3 | MP:0000029 | |
| MousePheno | craniofacial asymmetry | 2.93e-04 | 7 | 53 | 2 | MP:0008863 | |
| MousePheno | prenatal growth retardation | TRIM33 NCOA6 CAND1 G3BP1 UBR5 AMOT ROR2 GATA2 CHD7 KDM6A ZIC3 | 3.44e-04 | 869 | 53 | 11 | MP:0010865 |
| MousePheno | abnormal cerebellum vermis morphology | 3.65e-04 | 37 | 53 | 3 | MP:0000864 | |
| MousePheno | abnormal cerebellum posterior lobe morphology | 3.89e-04 | 8 | 53 | 2 | MP:0009962 | |
| MousePheno | abnormal cerebellum posterior vermis morphology | 3.89e-04 | 8 | 53 | 2 | MP:0000869 | |
| MousePheno | abnormal hindbrain morphology | 4.45e-04 | 485 | 53 | 8 | MP:0000841 | |
| MousePheno | interrupted aortic arch | 4.95e-04 | 41 | 53 | 3 | MP:0004157 | |
| MousePheno | absent posterior semicircular canal | 4.99e-04 | 9 | 53 | 2 | MP:0003163 | |
| MousePheno | abnormal face development | 4.99e-04 | 9 | 53 | 2 | MP:0030313 | |
| MousePheno | cranioschisis | 4.99e-04 | 9 | 53 | 2 | MP:0000919 | |
| MousePheno | abnormal extraembryonic tissue morphology | SLC25A3 TRIM33 NCOA6 CAND1 UBR5 AMOT ROR2 GATA2 ARID1A KDM6A ZIC3 | 5.01e-04 | 908 | 53 | 11 | MP:0002086 |
| MousePheno | interrupted aorta | 5.71e-04 | 43 | 53 | 3 | MP:0010544 | |
| MousePheno | postnatal lethality | ATP7B CPEB4 GATA2 NRG2 POU3F2 TAB2 CHD7 MBD5 FOXA2 CDON ZIC3 HOXA1 | 6.03e-04 | 1084 | 53 | 12 | MP:0002082 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | JPH1 NCOA6 ATP7B G3BP1 ROR2 WT1 GSX2 POU3F2 MBD5 ARID1A FOXA2 KDM6A HOXA1 | 7.15e-04 | 1269 | 53 | 13 | MP:0011111 |
| MousePheno | neonatal lethality | 7.29e-04 | 799 | 53 | 10 | MP:0002058 | |
| MousePheno | decreased embryo size | 7.49e-04 | 659 | 53 | 9 | MP:0001698 | |
| MousePheno | abnormal common crus morphology | 7.59e-04 | 11 | 53 | 2 | MP:0004922 | |
| MousePheno | fusion of glossopharyngeal and vagus nerve | 7.59e-04 | 11 | 53 | 2 | MP:0004568 | |
| MousePheno | abnormal primitive streak elongation | 7.59e-04 | 11 | 53 | 2 | MP:0012685 | |
| MousePheno | abnormal embryonic tissue morphology | TRIM33 UBR5 CECR2 ROR2 WT1 CHD7 ARID1A FOXA2 KDM6A CDON ZIC3 HOXA1 | 7.81e-04 | 1116 | 53 | 12 | MP:0002085 |
| MousePheno | pale yolk sac | 7.90e-04 | 110 | 53 | 4 | MP:0001722 | |
| MousePheno | pericardial effusion | 8.17e-04 | 111 | 53 | 4 | MP:0005312 | |
| MousePheno | abnormal male reproductive gland morphology | SLC25A3 MFSD14A PRDM9 CAND1 MAN2A2 ATXN2 ROR2 CPEB4 MARCHF6 WT1 JAZF1 CHD7 HSF5 | 8.35e-04 | 1290 | 53 | 13 | MP:0013325 |
| MousePheno | reduced female fertility | 8.52e-04 | 296 | 53 | 6 | MP:0001923 | |
| MousePheno | abnormal embryonic tissue physiology | 8.67e-04 | 297 | 53 | 6 | MP:0008932 | |
| MousePheno | abnormal blood vessel morphology | CCNT2 NCOA6 CAND1 UBR5 ZNF827 AMOT ROR2 GATA2 WT1 CHD7 ARID1A CDON ZIC3 HOXA1 | 8.95e-04 | 1472 | 53 | 14 | MP:0001614 |
| MousePheno | small testis | 9.15e-04 | 823 | 53 | 10 | MP:0001147 | |
| MousePheno | abnormal nose morphology | 9.58e-04 | 201 | 53 | 5 | MP:0002233 | |
| MousePheno | abnormal prenatal growth/weight/body size | TRIM33 NCOA6 CAND1 G3BP1 UBR5 AMOT ROR2 GATA2 WT1 CHD7 ARID1A FOXA2 KDM6A ZIC3 | 1.03e-03 | 1493 | 53 | 14 | MP:0004196 |
| MousePheno | caudal body truncation | 1.11e-03 | 54 | 53 | 3 | MP:0004073 | |
| MousePheno | abnormal middle ear ossicle morphology | 1.24e-03 | 56 | 53 | 3 | MP:0005105 | |
| MousePheno | abnormal palate development | 1.43e-03 | 129 | 53 | 4 | MP:0009653 | |
| MousePheno | small otic vesicle | 1.43e-03 | 15 | 53 | 2 | MP:0004310 | |
| MousePheno | abnormal embryo development | TRIM33 NCOA6 CAND1 G3BP1 UBR5 AMOT ROR2 GATA2 CHD7 ARID1A FOXA2 KDM6A ZIC3 | 1.46e-03 | 1370 | 53 | 13 | MP:0001672 |
| MousePheno | embryonic lethality during organogenesis | 1.47e-03 | 876 | 53 | 10 | MP:0006207 | |
| MousePheno | abnormal rostral-caudal axis patterning | 1.56e-03 | 132 | 53 | 4 | MP:0005221 | |
| MousePheno | abnormal pericardium morphology | 1.58e-03 | 225 | 53 | 5 | MP:0000288 | |
| MousePheno | small gonad | 1.59e-03 | 885 | 53 | 10 | MP:0001116 | |
| MousePheno | abnormal neural tube morphology | 1.61e-03 | 591 | 53 | 8 | MP:0002151 | |
| MousePheno | abnormal superior semicircular canal morphology | 1.64e-03 | 16 | 53 | 2 | MP:0003069 | |
| MousePheno | interrupted aortic arch, type b | 1.64e-03 | 16 | 53 | 2 | MP:0011659 | |
| MousePheno | abnormal brainstem morphology | 1.64e-03 | 227 | 53 | 5 | MP:0005277 | |
| MousePheno | abnormal notochord morphology | 1.74e-03 | 63 | 53 | 3 | MP:0002825 | |
| MousePheno | abnormal interventricular septum morphology | 1.79e-03 | 342 | 53 | 6 | MP:0000281 | |
| MousePheno | abnormal primary sex determination | 1.82e-03 | 901 | 53 | 10 | MP:0002211 | |
| MousePheno | small middle ear ossicles | 1.85e-03 | 17 | 53 | 2 | MP:0030123 | |
| MousePheno | absent olfactory bulb | 1.85e-03 | 17 | 53 | 2 | MP:0003451 | |
| MousePheno | abnormal vestibulocochlear ganglion morphology | 1.85e-03 | 17 | 53 | 2 | MP:0003703 | |
| MousePheno | abnormal gastrulation | 1.86e-03 | 469 | 53 | 7 | MP:0001695 | |
| MousePheno | abnormal facial morphology | 1.95e-03 | 910 | 53 | 10 | MP:0003743 | |
| MousePheno | abnormal forebrain morphology | NCOA6 ATP7B CECR2 GSX2 POU3F2 CHD7 MBD5 ARID1A KDM6A CDON ZIC3 | 1.96e-03 | 1072 | 53 | 11 | MP:0000783 |
| MousePheno | abnormal visceral endoderm morphology | 1.99e-03 | 66 | 53 | 3 | MP:0011186 | |
| MousePheno | decreased total body fat amount | 1.99e-03 | 475 | 53 | 7 | MP:0010025 | |
| MousePheno | abnormal adipose tissue amount | ZHX3 NCOA6 ROR2 PELI3 MAMLD1 POU3F2 TNKS CHD7 MBD5 MSTN HSF5 | 2.03e-03 | 1077 | 53 | 11 | MP:0005452 |
| MousePheno | abnormal testis size | 2.04e-03 | 915 | 53 | 10 | MP:0004849 | |
| MousePheno | increased trophoblast giant cell number | 2.08e-03 | 18 | 53 | 2 | MP:0009397 | |
| MousePheno | abnormal anterior visceral endoderm morphology | 2.08e-03 | 18 | 53 | 2 | MP:0008533 | |
| MousePheno | abnormal neurohypophysis morphology | 2.08e-03 | 18 | 53 | 2 | MP:0004164 | |
| MousePheno | decreased fetal cardiomyocyte proliferation | 2.08e-03 | 18 | 53 | 2 | MP:0011395 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF823 ZHX3 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 8.99e-05 | 775 | 67 | 11 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF823 ZHX3 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 9.20e-05 | 777 | 67 | 11 | PS00028 |
| Domain | Znf_C2H2-like | ZNF823 ZHX3 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 1.14e-04 | 796 | 67 | 11 | IPR015880 |
| Domain | Znf_C2H2 | ZNF823 ZHX3 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 1.26e-04 | 805 | 67 | 11 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF823 ZHX3 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 1.30e-04 | 808 | 67 | 11 | SM00355 |
| Domain | - | ZNF823 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 1.44e-04 | 679 | 67 | 10 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF823 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 1.70e-04 | 693 | 67 | 10 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF823 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 1.72e-04 | 694 | 67 | 10 | IPR013087 |
| Domain | Homeobox | 1.52e-03 | 234 | 67 | 5 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.58e-03 | 236 | 67 | 5 | PS00027 | |
| Domain | HOX | 1.61e-03 | 237 | 67 | 5 | SM00389 | |
| Domain | HOMEOBOX_2 | 1.67e-03 | 239 | 67 | 5 | PS50071 | |
| Domain | Homeobox_dom | 1.67e-03 | 239 | 67 | 5 | IPR001356 | |
| Domain | - | 3.46e-03 | 283 | 67 | 5 | 1.10.10.60 | |
| Domain | Homeobox_metazoa | 4.15e-03 | 90 | 67 | 3 | IPR020479 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.22e-06 | 29 | 46 | 4 | M48076 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 9.82e-05 | 143 | 46 | 5 | M39591 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 1.51e-04 | 32 | 46 | 3 | M23 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.78e-09 | 398 | 67 | 10 | 35016035 | |
| Pubmed | JPH1 TRIM33 GNL3L ATP7B UBR5 ZNF827 CECR2 ZNF589 CPEB4 FBRSL1 JAZF1 ARID1A ZNF646 | 1.81e-07 | 1116 | 67 | 13 | 31753913 | |
| Pubmed | 5.89e-07 | 83 | 67 | 5 | 28794006 | ||
| Pubmed | 7.71e-07 | 263 | 67 | 7 | 34702444 | ||
| Pubmed | 8.74e-07 | 268 | 67 | 7 | 33640491 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.00e-06 | 544 | 67 | 9 | 28473536 | |
| Pubmed | TRIM33 CCNT2 ZHX3 NCOA6 CAND1 G3BP1 UBR5 ATXN2 WT1 CHD7 ARID1A KDM6A | 1.17e-06 | 1103 | 67 | 12 | 34189442 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.22e-06 | 908 | 67 | 11 | 19274049 | |
| Pubmed | 1.93e-06 | 46 | 67 | 4 | 20301533 | ||
| Pubmed | Characterization of a new mouse mutant, flouncer, with a balance defect and inner ear malformation. | 3.66e-06 | 2 | 67 | 2 | 15353999 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | GNL3L CAND1 PXDN ATXN2 ZNF827 ROR2 ZNF589 FBRSL1 FNBP1L MBD5 ARID1A FBXO21 KDM6A | 4.52e-06 | 1489 | 67 | 13 | 28611215 |
| Pubmed | 4.92e-06 | 225 | 67 | 6 | 12168954 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.20e-06 | 351 | 67 | 7 | 38297188 | |
| Pubmed | 8.07e-06 | 529 | 67 | 8 | 14621295 | ||
| Pubmed | Ataxin-2-like is a regulator of stress granules and processing bodies. | 1.10e-05 | 3 | 67 | 2 | 23209657 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 21472823 | ||
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 19212333 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.44e-05 | 411 | 67 | 7 | 35182466 | |
| Pubmed | TRIM33 ZHX3 NCOA6 G3BP1 ATXN2 TLE1 GATA2 FBRSL1 CHD7 ARID1A KDM6A ZIC3 | 1.63e-05 | 1429 | 67 | 12 | 35140242 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SLC25A3 CCNT2 ATXN2 AMOT TAB2 TNKS FOXA2 ZIC3 DUSP11 HOXA1 ZNF646 | 1.76e-05 | 1203 | 67 | 11 | 29180619 |
| Pubmed | 1.79e-05 | 425 | 67 | 7 | 24999758 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 9854018 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 26138514 | ||
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 20108349 | ||
| Pubmed | Reversal of axonal pathways from rhombomere 3 correlates with extra Hox expression domains. | 2.19e-05 | 4 | 67 | 2 | 8096385 | |
| Pubmed | 2.19e-05 | 4 | 67 | 2 | 10767340 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.85e-05 | 457 | 67 | 7 | 32344865 | |
| Pubmed | 3.09e-05 | 638 | 67 | 8 | 31182584 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 23471918 | ||
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 10328927 | ||
| Pubmed | ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome. | 3.64e-05 | 5 | 67 | 2 | 17056598 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 10748198 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 4.03e-05 | 197 | 67 | 5 | 20811636 | |
| Pubmed | 4.66e-05 | 36 | 67 | 3 | 22278924 | ||
| Pubmed | Ihog and Boi elicit Hh signaling via Ptc but do not aid Ptc in sequestering the Hh ligand. | 5.46e-05 | 6 | 67 | 2 | 25231763 | |
| Pubmed | Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo. | 5.46e-05 | 6 | 67 | 2 | 15465489 | |
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 28926609 | ||
| Pubmed | 7.63e-05 | 7 | 67 | 2 | 12642491 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 17178841 | ||
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 10452853 | ||
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 1.02e-04 | 8 | 67 | 2 | 20735826 | |
| Pubmed | 1.02e-04 | 8 | 67 | 2 | 8287471 | ||
| Pubmed | 1.17e-04 | 396 | 67 | 6 | 26687479 | ||
| Pubmed | 1.26e-04 | 50 | 67 | 3 | 37974198 | ||
| Pubmed | 1.30e-04 | 9 | 67 | 2 | 16647304 | ||
| Pubmed | 1.30e-04 | 9 | 67 | 2 | 15872005 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.38e-04 | 588 | 67 | 7 | 38580884 | |
| Pubmed | 1.60e-04 | 808 | 67 | 8 | 20412781 | ||
| Pubmed | Hox and Pbx factors control retinoic acid synthesis during hindbrain segmentation. | 1.63e-04 | 10 | 67 | 2 | 21497760 | |
| Pubmed | 1.63e-04 | 10 | 67 | 2 | 7700351 | ||
| Pubmed | 1.63e-04 | 10 | 67 | 2 | 30571765 | ||
| Pubmed | 1.63e-04 | 10 | 67 | 2 | 23109420 | ||
| Pubmed | GDE2 promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK. | 1.63e-04 | 10 | 67 | 2 | 23329048 | |
| Pubmed | Cyclin F-Dependent Degradation of RBPJ Inhibits IDH1R132H-Mediated Tumorigenesis. | 1.99e-04 | 11 | 67 | 2 | 30254149 | |
| Pubmed | Trim33 is required for appropriate development of pre-cardiogenic mesoderm. | 1.99e-04 | 11 | 67 | 2 | 30940539 | |
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 28814342 | ||
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 11846474 | ||
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 14522873 | ||
| Pubmed | FoxH1 (Fast) functions to specify the anterior primitive streak in the mouse. | 1.99e-04 | 11 | 67 | 2 | 11358869 | |
| Pubmed | 1.99e-04 | 11 | 67 | 2 | 18003620 | ||
| Pubmed | Synergistic interaction between Gdf1 and Nodal during anterior axis development. | 2.38e-04 | 12 | 67 | 2 | 16564040 | |
| Pubmed | 2.38e-04 | 12 | 67 | 2 | 9671576 | ||
| Pubmed | 2.41e-04 | 453 | 67 | 6 | 29656893 | ||
| Pubmed | 2.74e-04 | 65 | 67 | 3 | 26655900 | ||
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 15329346 | ||
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 37861292 | ||
| Pubmed | Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. | 2.81e-04 | 13 | 67 | 2 | 17761849 | |
| Pubmed | Higher-Order Kidney Organogenesis from Pluripotent Stem Cells. | 2.81e-04 | 13 | 67 | 2 | 29129523 | |
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 30705426 | ||
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 17848411 | ||
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 8565836 | ||
| Pubmed | 2.90e-04 | 469 | 67 | 6 | 27634302 | ||
| Pubmed | 3.28e-04 | 14 | 67 | 2 | 21664576 | ||
| Pubmed | Zic3 is critical for early embryonic patterning during gastrulation. | 3.28e-04 | 14 | 67 | 2 | 16397896 | |
| Pubmed | GABAergic and glutamatergic identities of developing midbrain Pitx2 neurons. | 3.28e-04 | 14 | 67 | 2 | 21246650 | |
| Pubmed | 3.28e-04 | 14 | 67 | 2 | 36787740 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 3.28e-04 | 14 | 67 | 2 | 27626314 | |
| Pubmed | 3.57e-04 | 1153 | 67 | 9 | 29845934 | ||
| Pubmed | Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. | 3.78e-04 | 15 | 67 | 2 | 8837770 | |
| Pubmed | HNF-3 beta is essential for node and notochord formation in mouse development. | 3.78e-04 | 15 | 67 | 2 | 8069909 | |
| Pubmed | 3.78e-04 | 15 | 67 | 2 | 23071453 | ||
| Pubmed | 3.78e-04 | 15 | 67 | 2 | 9226455 | ||
| Pubmed | Foxa2 identifies a cardiac progenitor population with ventricular differentiation potential. | 3.78e-04 | 15 | 67 | 2 | 28195173 | |
| Pubmed | 3.78e-04 | 15 | 67 | 2 | 25458012 | ||
| Pubmed | 3.78e-04 | 15 | 67 | 2 | 17925232 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 3.86e-04 | 495 | 67 | 6 | 27705803 | |
| Pubmed | A high-resolution molecular atlas of the fetal mouse lower urogenital tract. | 4.18e-04 | 75 | 67 | 3 | 21905163 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 4.30e-04 | 182 | 67 | 4 | 32239614 | |
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 14736742 | ||
| Pubmed | Boc is a receptor for sonic hedgehog in the guidance of commissural axons. | 4.31e-04 | 16 | 67 | 2 | 17086203 | |
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 17504941 | ||
| Pubmed | Identification and characterization of VPO1, a new animal heme-containing peroxidase. | 4.31e-04 | 16 | 67 | 2 | 18929642 | |
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 10208738 | ||
| Pubmed | 4.31e-04 | 16 | 67 | 2 | 24368734 | ||
| Pubmed | 4.69e-04 | 78 | 67 | 3 | 28611094 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.86e-04 | 954 | 67 | 8 | 36373674 | |
| Pubmed | 4.87e-04 | 79 | 67 | 3 | 27325702 | ||
| Pubmed | 4.88e-04 | 17 | 67 | 2 | 26102480 | ||
| Pubmed | 4.88e-04 | 17 | 67 | 2 | 25263278 | ||
| Pubmed | 4.88e-04 | 17 | 67 | 2 | 26180087 | ||
| Interaction | PAX9 interactions | 2.24e-07 | 130 | 66 | 7 | int:PAX9 | |
| Interaction | SOX7 interactions | 2.82e-07 | 82 | 66 | 6 | int:SOX7 | |
| Interaction | ERG interactions | 6.56e-07 | 223 | 66 | 8 | int:ERG | |
| Interaction | SOX17 interactions | 6.77e-07 | 95 | 66 | 6 | int:SOX17 | |
| Interaction | EGR2 interactions | 1.43e-06 | 171 | 66 | 7 | int:EGR2 | |
| Interaction | TBR1 interactions | 1.88e-06 | 113 | 66 | 6 | int:TBR1 | |
| Interaction | TBXT interactions | 2.19e-06 | 116 | 66 | 6 | int:TBXT | |
| Interaction | GATA2 interactions | 3.92e-06 | 199 | 66 | 7 | int:GATA2 | |
| Interaction | PAX2 interactions | 8.65e-06 | 85 | 66 | 5 | int:PAX2 | |
| Interaction | EN2 interactions | 1.19e-05 | 14 | 66 | 3 | int:EN2 | |
| Interaction | SOX10 interactions | 1.27e-05 | 92 | 66 | 5 | int:SOX10 | |
| Interaction | FOXI1 interactions | 1.27e-05 | 92 | 66 | 5 | int:FOXI1 | |
| Interaction | SOX9 interactions | 1.65e-05 | 97 | 66 | 5 | int:SOX9 | |
| Interaction | CRX interactions | 1.92e-05 | 254 | 66 | 7 | int:CRX | |
| Interaction | LHX1 interactions | 2.21e-05 | 103 | 66 | 5 | int:LHX1 | |
| Interaction | NELL2 interactions | 2.72e-05 | 53 | 66 | 4 | int:NELL2 | |
| Interaction | ALG13 interactions | 2.99e-05 | 183 | 66 | 6 | int:ALG13 | |
| Interaction | PAX8 interactions | 3.17e-05 | 111 | 66 | 5 | int:PAX8 | |
| Interaction | HNF4A interactions | 3.20e-05 | 275 | 66 | 7 | int:HNF4A | |
| Interaction | GATA3 interactions | 3.37e-05 | 187 | 66 | 6 | int:GATA3 | |
| Interaction | TPRX2 interactions | 3.39e-05 | 56 | 66 | 4 | int:TPRX2 | |
| Interaction | TLX3 interactions | 4.58e-05 | 291 | 66 | 7 | int:TLX3 | |
| Interaction | FEV interactions | 5.33e-05 | 203 | 66 | 6 | int:FEV | |
| Interaction | PAX7 interactions | 5.38e-05 | 124 | 66 | 5 | int:PAX7 | |
| Interaction | SP7 interactions | 6.03e-05 | 304 | 66 | 7 | int:SP7 | |
| Interaction | VSX1 interactions | 6.49e-05 | 66 | 66 | 4 | int:VSX1 | |
| Interaction | TLE1 interactions | 6.96e-05 | 213 | 66 | 6 | int:TLE1 | |
| Interaction | RSPH1 interactions | 6.99e-05 | 131 | 66 | 5 | int:RSPH1 | |
| Interaction | GCM1 interactions | 7.30e-05 | 68 | 66 | 4 | int:GCM1 | |
| Interaction | RNF43 interactions | 7.46e-05 | 427 | 66 | 8 | int:RNF43 | |
| Interaction | SMG7 interactions | 8.16e-05 | 319 | 66 | 7 | int:SMG7 | |
| Interaction | TLX2 interactions | 1.02e-04 | 142 | 66 | 5 | int:TLX2 | |
| Interaction | ELF5 interactions | 1.21e-04 | 147 | 66 | 5 | int:ELF5 | |
| Interaction | SOX6 interactions | 1.64e-04 | 157 | 66 | 5 | int:SOX6 | |
| Interaction | R3HDM1 interactions | 1.66e-04 | 84 | 66 | 4 | int:R3HDM1 | |
| Interaction | CEBPA interactions | TRIM33 CCNT2 ZHX3 NCOA6 CAND1 G3BP1 UBR5 ATXN2 GATA2 WT1 CHD7 ARID1A KDM6A | 1.70e-04 | 1245 | 66 | 13 | int:CEBPA |
| Interaction | IRF4 interactions | 1.74e-04 | 85 | 66 | 4 | int:IRF4 | |
| Interaction | PAX6 interactions | 1.91e-04 | 366 | 66 | 7 | int:PAX6 | |
| Interaction | FOXA2 interactions | 2.04e-04 | 35 | 66 | 3 | int:FOXA2 | |
| Interaction | LHX4 interactions | 2.13e-04 | 166 | 66 | 5 | int:LHX4 | |
| Interaction | PRRC2B interactions | 2.29e-04 | 265 | 66 | 6 | int:PRRC2B | |
| Interaction | TLX1 interactions | 2.72e-04 | 175 | 66 | 5 | int:TLX1 | |
| Interaction | TEAD1 interactions | 2.79e-04 | 176 | 66 | 5 | int:TEAD1 | |
| Interaction | BMI1 interactions | 2.84e-04 | 659 | 66 | 9 | int:BMI1 | |
| Interaction | ANKS3 interactions | 3.27e-04 | 41 | 66 | 3 | int:ANKS3 | |
| Interaction | AR interactions | TRIM33 ZHX3 NCOA6 CAND1 G3BP1 UBR5 TLE1 TAB2 CHD7 ARID1A KDM6A | 3.47e-04 | 992 | 66 | 11 | int:AR |
| Interaction | RBBP5 interactions | 3.51e-04 | 287 | 66 | 6 | int:RBBP5 | |
| Interaction | SMAP2 interactions | 3.87e-04 | 189 | 66 | 5 | int:SMAP2 | |
| Interaction | UBAP2L interactions | 4.29e-04 | 298 | 66 | 6 | int:UBAP2L | |
| Interaction | KLF5 interactions | 4.46e-04 | 195 | 66 | 5 | int:KLF5 | |
| Interaction | NUP35 interactions | 4.64e-04 | 424 | 66 | 7 | int:NUP35 | |
| Interaction | RFPL4B interactions | 5.22e-04 | 48 | 66 | 3 | int:RFPL4B | |
| Interaction | FOS interactions | 5.47e-04 | 312 | 66 | 6 | int:FOS | |
| Interaction | PAGR1 interactions | 6.24e-04 | 51 | 66 | 3 | int:PAGR1 | |
| Interaction | MCRIP2 interactions | 6.24e-04 | 51 | 66 | 3 | int:MCRIP2 | |
| Interaction | NFIC interactions | 6.25e-04 | 210 | 66 | 5 | int:NFIC | |
| Cytoband | 2q32.2 | 2.18e-04 | 15 | 67 | 2 | 2q32.2 | |
| Cytoband | 5q33.1 | 6.67e-04 | 26 | 67 | 2 | 5q33.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF823 ZHX3 PRDM9 ZNF827 ZNF589 WT1 JAZF1 ZNF784 ZNF446 ZIC3 ZNF646 | 5.96e-06 | 718 | 53 | 11 | 28 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.26e-03 | 161 | 53 | 4 | 593 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.48e-06 | 466 | 66 | 9 | M13522 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TRIM33 ZHX3 CAND1 UBR5 ATXN2 TLE1 MARCHF6 MAMLD1 TAB2 TNKS FNBP1L | 8.81e-06 | 856 | 66 | 11 | M4500 |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-06 | 70 | 66 | 4 | 37e34ef782b253c43628d5bb2fe5e0294573d0ef | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 3.65e-06 | 157 | 66 | 5 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.72e-06 | 192 | 66 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.97e-06 | 193 | 66 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.97e-06 | 193 | 66 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| Disease | monocyte percentage of leukocytes | 2.40e-05 | 731 | 63 | 9 | EFO_0007989 | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 8.66e-05 | 40 | 63 | 3 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | quinolinate measurement | 9.36e-05 | 7 | 63 | 2 | EFO_0800175 | |
| Disease | red blood cell density measurement | 1.00e-04 | 880 | 63 | 9 | EFO_0007978 | |
| Disease | urate measurement | 1.14e-04 | 895 | 63 | 9 | EFO_0004531 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.21e-04 | 225 | 63 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | glucose measurement | 1.60e-04 | 380 | 63 | 6 | EFO_0004468 | |
| Disease | uric acid measurement | 3.17e-04 | 610 | 63 | 7 | EFO_0004761 | |
| Disease | Crohn's disease | 3.56e-04 | 441 | 63 | 6 | EFO_0000384 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 4.75e-04 | 169 | 63 | 4 | DOID:3908 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 5.19e-04 | 173 | 63 | 4 | C0023467 | |
| Disease | lymphocyte percentage of leukocytes | 5.30e-04 | 665 | 63 | 7 | EFO_0007993 | |
| Disease | feeling nervous measurement | 8.65e-04 | 87 | 63 | 3 | EFO_0009597 | |
| Disease | left ventricular structural measurement | 8.94e-04 | 88 | 63 | 3 | EFO_0008205 | |
| Disease | coronary artery disease | 9.35e-04 | 1194 | 63 | 9 | EFO_0001645 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.36e-03 | 224 | 63 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.41e-03 | 26 | 63 | 2 | DOID:234 (is_implicated_in) | |
| Disease | eosinophil measurement | 1.61e-03 | 108 | 63 | 3 | EFO_0803540 | |
| Disease | cancer | 1.65e-03 | 400 | 63 | 5 | MONDO_0004992 | |
| Disease | Bilateral Wilms Tumor | 1.76e-03 | 29 | 63 | 2 | C2930471 | |
| Disease | pappalysin‐1 measurement | 1.76e-03 | 29 | 63 | 2 | EFO_0010618 | |
| Disease | type 1 diabetes mellitus | 1.80e-03 | 242 | 63 | 4 | MONDO_0005147 | |
| Disease | neuroimaging measurement | 1.92e-03 | 1069 | 63 | 8 | EFO_0004346 | |
| Disease | serum IgA measurement | 2.00e-03 | 31 | 63 | 2 | EFO_0004912 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHRAGTHHSPQNQFP | 486 | Q96KV6 | |
| QHTHQHQHTFAPFPA | 451 | Q9HCM7 | |
| NQGDHSAHLPRPQQH | 341 | Q4VCS5 | |
| FQQGPSISLHSGLHH | 381 | O60583 | |
| LRHHQFLQHSSPGSP | 486 | Q2NKJ3 | |
| GFHASLAQRNPNAHH | 626 | P35670 | |
| RHLHNPSSGQNFQHL | 536 | Q3KP44 | |
| PSSGQNFQHLSPNRH | 541 | Q3KP44 | |
| APSLRHSVQQFHHHP | 246 | Q9P2D1 | |
| QHFPPRGFQSNHPHS | 1176 | Q9BXF3 | |
| AGPQQNSHDHGFPNH | 196 | O14497 | |
| NMNVHSLPHGHHQPF | 536 | O94952 | |
| QGNRFHFDIKPPLHH | 231 | Q9H4B0 | |
| AHLARANPFNTPHLQ | 6 | Q00325 | |
| AQHARNGHPQALPAA | 676 | Q7Z3E5 | |
| PAPSPVQHHQHQAAQ | 1166 | Q99700 | |
| GLRHHTINFHPPVSA | 221 | Q86VZ6 | |
| GGHAVSHPPVQQQAH | 451 | O15550 | |
| HHIPNPSNGELHSQY | 536 | Q9HDC5 | |
| CNHSPQVFHPHVQAL | 506 | Q86VP6 | |
| HHHHQPQQPGSAAAA | 136 | Q9BZM3 | |
| NLHPPHFASFVHQGQ | 1026 | Q9NYQ8 | |
| RSFHLADPCQHSPQH | 1101 | Q6ZU69 | |
| CPAHQNRSLANGPSH | 446 | O14511 | |
| LEHAAPPFNAAGHHQ | 176 | O60337 | |
| HHHHPQPATYQTSGN | 71 | P49639 | |
| HHPPISAFHAEGLNN | 651 | Q9BXW6 | |
| GSHSHPHNTQAPGEA | 466 | Q96MC6 | |
| VNSLPSSHGHHFPNV | 1186 | Q14686 | |
| SSHGHHFPNVAAPTQ | 1191 | Q14686 | |
| HVERNHSSQNFPGPS | 406 | Q9NQV7 | |
| VLNAQHPDSHHPGLA | 16 | P23769 | |
| PGHFFHLLNVQHPDL | 351 | A4D1B5 | |
| NQEVRGPPQQHGHHN | 511 | Q5T0N5 | |
| IQGHSAPRHFHTQTQ | 291 | O75319 | |
| HPDSHQLFIGNLPHE | 336 | Q13283 | |
| FHNAQPIHPSARHLT | 346 | Q4KMG0 | |
| PQHQHGNSFTSRQDP | 656 | Q13495 | |
| HDPTRHQNGGNFPRS | 31 | P49641 | |
| TNFVHSNSPVPNHHL | 766 | Q9P267 | |
| PHHHQNATPSPAAFI | 31 | Q17RY0 | |
| APGNHQHPHRITNFF | 56 | P19622 | |
| PLPQAFNTSGNHTAH | 266 | P60507 | |
| HAAPVTRRQFPHGAH | 531 | Q86T96 | |
| QQQQAAAHLLGPPHH | 341 | Q9Y261 | |
| GPLHHFHNPHFRRDQ | 106 | Q4G112 | |
| HLQRQHSNPGHAGPF | 616 | Q9UPN9 | |
| FQARGPHFNPSAIHN | 616 | Q9NYJ8 | |
| AQTPLPHGTHAFHAA | 431 | Q8N2H9 | |
| PSAPHFVHPNDHANR | 41 | Q9NVN8 | |
| YPHTHLVHQANPRGS | 321 | O14793 | |
| FVRLGPTHSPNHNFQ | 151 | Q01974 | |
| GALQSNGHPLSHAHQ | 46 | P20265 | |
| TGHLPFEPNNHHHFG | 81 | Q8N1N0 | |
| GHPSPTGHVDNNQVH | 171 | O60481 | |
| SHQHSFQTHERPPTG | 146 | P16415 | |
| QQLQAQHLSHGHGPP | 126 | Q04724 | |
| FHLAPARAGHHPNQY | 61 | Q9BTP6 | |
| HHHHQQQLQPAPGAS | 11 | O95271 | |
| HNNRITHLVPGTFNH | 166 | Q92626 | |
| HFQNHRPGEATSAQP | 866 | O15015 | |
| GHTPSHHAAQFPNHS | 161 | P19544 | |
| NNHVHGQPYTGPAAH | 2511 | O00507 | |
| GNHGHQEPASTSFHP | 191 | Q9NWS9 | |
| GSNLSFSPPSHHAQQ | 151 | Q17R98 | |
| ELHNHPIPGFHAGNQ | 101 | Q86UQ0 | |
| FLSLQQQPPVHAQHH | 271 | Q9H4I2 | |
| LQQGHPLHSFQAHQS | 231 | Q6ZQQ6 | |
| GHPNHPLHASQNSAR | 1866 | O95071 | |
| RHGAPNPAQSHLHVQ | 31 | Q6ZVH6 | |
| NFRKHQRTHFHGPGP | 266 | Q8NCA9 |